121 related articles for article (PubMed ID: 17299396)
21. Erythropoietin disrupts hypoxia-inducible factor signaling in ovarian cancer cells.
Hale SA; Wong C; Lounsbury KM
Gynecol Oncol; 2006 Jan; 100(1):14-9. PubMed ID: 16226302
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin protects against apoptosis and increases expression of non-neuronal cell markers in the hypoxia-injured developing brain.
Yamada M; Burke C; Colditz P; Johnson DW; Gobe GC
J Pathol; 2011 May; 224(1):101-9. PubMed ID: 21404277
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin protects the developing retina in an ovine model of endotoxin-induced retinal injury.
Loeliger MM; Mackintosh A; De Matteo R; Harding R; Rees SM
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2656-61. PubMed ID: 21245409
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin downregulates bax and DP5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury.
Kumral A; Genc S; Ozer E; Yilmaz O; Gokmen N; Koroglu TF; Duman N; Genc K; Ozkan H
Biol Neonate; 2006; 89(3):205-10. PubMed ID: 16319448
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.
Li Y; Lu Z; Keogh CL; Yu SP; Wei L
J Cereb Blood Flow Metab; 2007 May; 27(5):1043-54. PubMed ID: 17077815
[TBL] [Abstract][Full Text] [Related]
26. The potential role of JAK2/STAT3 pathway on the anti-apoptotic effect of recombinant human erythropoietin (rhEPO) after experimental traumatic brain injury of rats.
Zhao J; Li G; Zhang Y; Su X; Hang C
Cytokine; 2011 Nov; 56(2):343-50. PubMed ID: 21843949
[TBL] [Abstract][Full Text] [Related]
27. The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats.
Keogh CL; Yu SP; Wei L
J Pharmacol Exp Ther; 2007 Aug; 322(2):521-8. PubMed ID: 17494864
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats.
Böcker-Meffert S; Rosenstiel P; Röhl C; Warneke N; Held-Feindt J; Sievers J; Lucius R
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2021-6. PubMed ID: 12037014
[TBL] [Abstract][Full Text] [Related]
29. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis.
Yang J; Xiao Z; Li T; Gu X; Fan B
Int J Oncol; 2012 Apr; 40(4):1230-7. PubMed ID: 22086127
[TBL] [Abstract][Full Text] [Related]
31. Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy.
Morais C; Small DM; Vesey DA; Martin J; Johnson DW; Gobe GC
Biochem Biophys Res Commun; 2014 Feb; 444(3):332-7. PubMed ID: 24462876
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.
Mihov D; Bogdanov N; Grenacher B; Gassmann M; Zünd G; Bogdanova A; Tavakoli R
Eur J Cardiothorac Surg; 2009 May; 35(5):839-46; discussion 846. PubMed ID: 19237290
[TBL] [Abstract][Full Text] [Related]
33. Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage.
Chen G; Zhang S; Shi J; Ai J; Hang C
Cytokine; 2009 Mar; 45(3):162-8. PubMed ID: 19144539
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin decreases carbon tetrachloride-induced hepatic fibrosis by inhibiting transforming growth factor-beta.
Park SY; Lee JY; Tak WY; Kweon YO; Lee MS
Chin Med J (Engl); 2012 Sep; 125(17):3098-103. PubMed ID: 22932188
[TBL] [Abstract][Full Text] [Related]
35. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
[TBL] [Abstract][Full Text] [Related]
36. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure.
Teixeira AM; Garrido P; Santos P; Alves R; Parada B; Costa E; Almeida A; Teixeira-Lemos E; Sereno J; Pinto R; Belo L; Santos-Silva A; Teixeira F; Reis F
Ren Fail; 2010; 32(9):1073-80. PubMed ID: 20863212
[TBL] [Abstract][Full Text] [Related]
38. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1alpha (HIF-1alpha), and microvessel density in endometrial tissue in women with adenomyosis.
Goteri G; Lucarini G; Montik N; Zizzi A; Stramazzotti D; Fabris G; Tranquilli AL; Ciavattini A
Int J Gynecol Pathol; 2009 Mar; 28(2):157-63. PubMed ID: 19188818
[TBL] [Abstract][Full Text] [Related]
39. Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats.
Kelleher DK; Mattheinsen U; Thews O; Vaupel P
Cancer Res; 1996 Oct; 56(20):4728-34. PubMed ID: 8840991
[TBL] [Abstract][Full Text] [Related]
40. Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis.
Atkin G; Taylor NJ; Daley FM; Stirling JJ; Richman P; Glynne-Jones R; d'Arcy JA; Collins DJ; Padhani AR
Br J Surg; 2006 Aug; 93(8):992-1000. PubMed ID: 16673354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
